{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:46:21Z","timestamp":1791229581929,"version":"4.1.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T00:00:00Z","timestamp":1479168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute for Health Research School for Primary Care Research (NIHR SPCR)"},{"name":"National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care for West Midlands (CLAHRC-WM)","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002169","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T14:00:30Z","timestamp":1479218430000},"page":"e1002169","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Under-prescribing of Prevention Drugs and Primary Prevention of Stroke and Transient Ischaemic Attack in UK General Practice: A Retrospective Analysis"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9783-9413","authenticated-orcid":true,"given":"Grace M.","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1856-837X","authenticated-orcid":true,"given":"Melanie","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3891-5068","authenticated-orcid":false,"given":"Max G.","family":"Feltham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5919-3191","authenticated-orcid":true,"given":"Ronan","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fitzmaurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. K.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,11,15]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1016\/S2214-109X(13)70089-5","article-title":"Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990\u20132010: findings from the Global Burden of Disease Study 2010","volume":"1","author":"RV Krishnamurthi","year":"2013","journal-title":"Lancet Glob Health"},{"issue":"Suppl 6","key":"ref2","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1212\/WNL.62.8_suppl_6.S7","article-title":"Risk factors for TIA and TIA as a risk factor for stroke","volume":"62","author":"RL Sacco","year":"2004","journal-title":"Neurology"},{"key":"ref3","article-title":"Clinical Guideline 181","year":"2014"},{"key":"ref4","article-title":"Clinical Guideline 127","year":"2011"},{"key":"ref5","article-title":"Clinical Guideline 180","year":"2014"},{"issue":"3","key":"ref6","first-page":"CD001927","article-title":"Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks","author":"MI Aguilar","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"ref7","first-page":"CD006186","article-title":"Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks","author":"MI Aguilar","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"19","key":"ref8","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","article-title":"Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis","volume":"289","author":"BM Psaty","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"ref9","first-page":"CD004816","article-title":"Statins for the primary prevention of cardiovascular disease","author":"F Taylor","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"e92388","DOI":"10.1371\/journal.pone.0092388","article-title":"Statins for the prevention of stroke: a meta-analysis of randomized controlled trials","volume":"9","author":"W Wang","year":"2014","journal-title":"PLoS ONE"},{"issue":"545","key":"ref11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3399\/096016407782604965","article-title":"Hypertension guideline recommendations in general practice: awareness, agreement, adoption, and adherence","volume":"57","author":"C Heneghan","year":"2007","journal-title":"Br J Gen Pract"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"e003423","DOI":"10.1136\/bmjopen-2013-003423","article-title":"Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study","volume":"3","author":"M Joffres","year":"2013","journal-title":"BMJ Open"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"e84238","DOI":"10.1371\/journal.pone.0084238","article-title":"Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies","volume":"9","author":"R Khatib","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/01.ATV.12.5.584","article-title":"Diagnosis of heterozygous familial hypercholesterolemia. DNA analysis complements clinical examination and analysis of serum lipid levels","volume":"12","author":"P Koivisto","year":"1992","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/HJR.0b013e328339cc86","article-title":"High cardiovascular risk and poor adherence to guidelines in 11 069 patients of middle age and older in primary care centres","volume":"17","author":"L Missault","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","article-title":"Underuse of oral anticoagulants in atrial fibrillation: a systematic review","volume":"123","author":"IM Ogilvie","year":"2010","journal-title":"Am J Med"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1468-1331.2012.03804.x","article-title":"Stroke due to atrial fibrillation in a population-based stroke registry (Ludwigshafen Stroke Study) CHADS2, CHA2DS2-VASc score, underuse of oral anticoagulation, and implications for preventive measures","volume":"20","author":"F Palm","year":"2013","journal-title":"Eur J Neurol"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.thromres.2006.12.019","article-title":"Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: the appropriate use and barriers to oral anticoagulant therapy","volume":"120","author":"SL Partington","year":"2007","journal-title":"Thromb Res"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/vhrm.2006.2.4.507","article-title":"Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients\u2019 risk level","volume":"2","author":"D Roccatagliata","year":"2006","journal-title":"Vasc Health Risk Manag"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e006622","DOI":"10.1136\/bmjopen-2014-006622","article-title":"Retrospective case review of missed opportunities for primary prevention of stroke and TIA in primary care: protocol paper","volume":"4","author":"GM Moran","year":"2014","journal-title":"BMJ Open"},{"key":"ref21","unstructured":"IMS Health. Ethics. London: IMS Health; 2015 [cited 2016 Oct 15]. Available from: http:\/\/csdmruk.cegedim.com\/our-data\/ethics.shtml<\/ext-link>."},{"key":"ref22","unstructured":"The Health Improvement Network. Partnership. London: CSD Health Research; 2016 [cited 2016 Oct 15]. Available from: http:\/\/www.thin-uk.com\/<\/ext-link>."},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/pds.1919","article-title":"Validation of ischemic cerebrovascular diagnoses in the health improvement network (THIN)","volume":"19","author":"A Ruigomez","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref24","unstructured":"In Practice Systems. The Health Improvement Network (THIN). London: In Practice Systems; 2016 [cited 2016 Oct 15]. Available from: http:\/\/www.inps.co.uk\/vision\/health-improvement-network-thin<\/ext-link>."},{"key":"ref25","unstructured":"IMS Health. Statistics. London: IMS Health; 2005 [cited 2016 Oct 15]. Available from: http:\/\/csdmruk.cegedim.com\/our-data\/statistics.shtml<\/ext-link>."},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/pds.1688","article-title":"The importance of defining periods of complete mortality reporting for research using automated data from primary care","volume":"18","author":"A Maguire","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref27","article-title":"Clinical Guideline 36","year":"2006"},{"key":"ref28","article-title":"Clinical Guideline 67","year":"2008"},{"issue":"9586","key":"ref29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"J Mant","year":"2007","journal-title":"Lancet"},{"key":"ref30","year":"2016"},{"key":"ref31","year":"2016"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/02813430802202111","article-title":"Barriers to adherence to hypertension guidelines among GPs in southern Sweden: a survey","volume":"26","author":"P Midlov","year":"2008","journal-title":"Scand J Prim Health Care"},{"key":"ref33","year":"2014"},{"key":"ref34","year":"2015"},{"key":"ref35","year":"2016"},{"issue":"9499","key":"ref36","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(05)67702-1","article-title":"Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)","volume":"366","author":"PM Rothwell","year":"2005","journal-title":"Lancet"},{"issue":"9859","key":"ref37","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"CJL Murray","year":"2012","journal-title":"Lancet"},{"issue":"9859","key":"ref38","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"R Lozano","year":"2012","journal-title":"Lancet"},{"key":"ref39","year":"2014"},{"key":"ref40","unstructured":"United Nations Department of Economic and Social Affairs. World population prospects, the 2015 revision. United Nations Department of Economic and Social Affairs; 2015 [cited 2016 Oct 15]. Available from: http:\/\/esa.un.org\/wpp\/Excel-Data\/population.htm<\/ext-link>."},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2296-10-24","article-title":"Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study","volume":"10","author":"E AB","year":"2009","journal-title":"BMC Fam Pract"},{"issue":"494","key":"ref42","first-page":"684","article-title":"A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care","volume":"53","author":"J Kedward","year":"2003","journal-title":"Br J Gen Pract"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/2047487314525531","article-title":"What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice","volume":"21","author":"JA Finegold","year":"2014","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/ageing\/afr097","article-title":"Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review","volume":"40","author":"D Pugh","year":"2011","journal-title":"Age Ageing"},{"issue":"11","key":"ref45","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study","volume":"271","author":"EJ Benjamin","year":"1994","journal-title":"JAMA"},{"issue":"8","key":"ref46","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study","volume":"129","author":"SS Chugh","year":"2013","journal-title":"Circulation"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation. The Framingham Study","volume":"27","author":"HJ Lin","year":"1996","journal-title":"Stroke"},{"issue":"8","key":"ref48","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"PA Wolf","year":"1991","journal-title":"Stroke"},{"issue":"9623","key":"ref49","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(08)60655-8","article-title":"Global burden of blood-pressure-related disease, 2001","volume":"371","author":"CMM Lawes","year":"2008","journal-title":"Lancet"},{"issue":"15","key":"ref50","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don\u2019t physicians follow clinical practice guidelines? A framework for improvement","volume":"282","author":"MD Cabana","year":"1999","journal-title":"JAMA"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2296-12-59","article-title":"Patient and general practitioner attitudes to taking medication to prevent cardiovascular disease after receiving detailed information on risks and benefits of treatment: a qualitative study","volume":"12","author":"N Gale","year":"2011","journal-title":"BMC Fam Pract"},{"issue":"5","key":"ref52","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/HJR.0b013e3283383f30","article-title":"EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries","volume":"17","author":"K Kotseva","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.HYP.0000103630.72812.10","article-title":"Hypertension treatment and control in five European countries, Canada, and the United States","volume":"43","author":"K Wolf-Maier","year":"2004","journal-title":"Hypertension"},{"issue":"Suppl 1","key":"ref54","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1161\/CIRCOUTCOMES.114.001556","article-title":"Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation","volume":"8","author":"GY Lip","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T20:11:56Z","timestamp":1540325516000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002169"}},"subtitle":[],"editor":[{"given":"Kazem","family":"Rahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,15]]},"references-count":54,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002169","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,15]]}}}